CryoPort Inc(CYRX) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 14 at 8:18 AM ET (Korea 9/14 21:18)
Full metrics table
| Index | RUT | P/E | - | EPS (ttm) | -0.82 | Insider Own | 4.39% | Shs Outstand | 50.6M | Perf Week | -1.95% |
| Market Cap | 0.79B | Forward P/E | - | EPS next Y | 18.19% | Insider Trans | -12.46% | Shs Float | 48.4M | Perf Month | 5.07% |
| Enterprise Value | 0.67B | PEG | - | EPS next Q | -0.18 | Inst Own | 90.25% | Short Float | 5.6% | Perf Quarter | 8.14% |
| Income | -0.04B | P/S | 4.22 | EPS this Y | -156.27% | Inst Trans | 2.02% | Short Ratio | 4.23 | Perf Half Y | 101.42% |
| Sales | 0.19B | P/B | 1.77 | EPS next 5Y | - | ROA | -4.3% | Short Interest | 2.71M | Perf YTD | 61.98% |
| Book/sh | 8.77 | P/C | 1.99 | EPS past 3/5Y | -0.23% 13.68% | ROE | -6.54% | 52W High | -9.59% ($17.20) | Perf Year | 64.2% |
| Cash/sh | 7.83 | P/FCF | - | Sales past 3/5Y | -9.45% 17.49% | ROIC | -6.17% | 52W Low | 104.34% ($7.61) | Perf 3Y | 24.1% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 17.42% | Gross Margin | 40.16% | Volatility(W/M) | 4.03% 4.02% | Perf 5Y | -76.16% |
| Dividend TTM | - | EV/Sales | 3.59 | Sales Y/Y TTM | -8.01% | Oper. Margin | -21.25% | ATR (14) | 0.66 | Perf 10Y | 673.67% |
| Dividend Ex-Date | - | Quick Ratio | 1.98 | EPS Q/Q | 24.23% | Profit Margin | -21.92% | RSI (14) | 47.98 | Recom | 1.22 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.08 | Sales Q/Q | 7.74% | SMA20 | -2.36% ($15.93) | Beta | 1.97 | Target Price | $19.33 |
| Payout | - | Debt/Eq | 0.47 | Earnings | 2026/8/6 | SMA50 | -0.8% ($15.68) | Rel Volume | 0.73 | Prev Close | $15.27 |
| Employees | 738 | LT Debt/Eq | 0.09 | EPS/Sales Surpr. | -3.47% 1.65% | SMA200 | 29.87% ($11.97) | Avg Volume(3M) | 0.64M | Price | $15.55 |
| IPO | 2005/1/31 | Option/Short | Yes/Yes | Trades | 6670 | Volume | 467,492 | Change | 1.83% |
Company
CYRX is a Industrials sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
❄️ Cryoport (CYRX) is a cold-chain logistics company specializing in temperature-sensitive materials for the life sciences industry. It provides integrated solutions spanning ultra-low temperature transportation and storage for cell and gene therapies, vaccines, and biological specimens, operating a life sciences–focused logistics platform that connects biopharmaceutical companies, research institutions, and clinical trial sites on a global scale.
Over the past 1 year, on the higher side
10% below its 1-year high.
CYRX has weak earning power
Losses or thin margins. Early-stage growth or weakening competitiveness
Tap to view numbers
Growth has stalled
Earnings are expected to grow by -156.3% this year.
Tap to view numbers
The stock looks undervalued
Trading at - times earnings.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
The outlook is positive
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Would have changed by +24.1% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 90.3%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
QQQS 0.01%
ISMD 0.00%
SGRW 0.00%
EES 0.00%
SCDS 0.00%It ranks #4 in the industry
Based on market cap of $788M.
CYRX $788M PER -
UPS $85B PER 18.7
FDX $74B PER 16.8
JBHT $25B PER 38.3
FAQ
What kind of company is CYRX?
CYRX belongs to the Industrials sector and operates in the Integrated Freight & Logistics industry.
What is the market cap of CYRX?
The market cap of CYRX is approximately $788M, ranking 2,843 within its sector.
What is the 52-week high and low for CYRX?
CYRX has recorded a 52-week high of $17.20 and a low of $7.61.
